This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Jun 20;31(18):2363.

doi: 10.1200/JCO.2012.48.3743.

Reply to M.L. Friedlander et al

David R Spriggs

PMID: 23930276
DOI: 10.1200/JCO.2012.48.3743

Comment

Reply to M.L. Friedlander et al

David R Spriggs. J Clin Oncol. 2013.

. 2013 Jun 20;31(18):2363.

doi: 10.1200/JCO.2012.48.3743.

Author

David R Spriggs

PMID: 23930276
DOI: 10.1200/JCO.2012.48.3743

No abstract available

PubMed Disclaimer

Comment on

Drug development for chronic cancers: time to think differently?
Spriggs DR. Spriggs DR. J Clin Oncol. 2012 Nov 1;30(31):3779-80. doi: 10.1200/JCO.2012.42.3269. Epub 2012 Sep 17. J Clin Oncol. 2012. PMID: 22987092 No abstract available.
Clinical trials of palliative chemotherapy in platinum-resistant or -refractory ovarian cancer: time to think differently?
Friedlander ML, Stockler MR, Butow P, King MT, McAlpine J, Tinker A, Ledermann JA. Friedlander ML, et al. J Clin Oncol. 2013 Jun 20;31(18):2362. doi: 10.1200/JCO.2012.47.7927. Epub 2013 May 13. J Clin Oncol. 2013. PMID: 23669225 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information